Insider Trading March 19, 2026

First Citizens CEO Makes Small Class B Stock Purchase Amid Strategic Moves and Credit Concerns

Frank B. Holding Jr. buys $151,900 of Class B shares as the bank weighs M&A to surpass $250 billion in assets while the sector grapples with private credit losses

By Maya Rios FCNCA KEY
First Citizens CEO Makes Small Class B Stock Purchase Amid Strategic Moves and Credit Concerns
FCNCA KEY

Frank B. Holding Jr., chairman and CEO of First Citizens BancShares (FCNCA), purchased 98 shares of Class B common stock between March 17 and March 19, 2026, at $1,550 per share for a total of $151,900. The transactions were disclosed on a Form 4: 92 shares were bought directly on March 19 and six shares were acquired indirectly through the Frank B. Holding Jr. 2025 #1 GRAT on March 17 and 19. After these purchases, Holding directly owns 2,841 Class B shares and retains significant indirect holdings of both Class A and Class B stock through trusts and custodial structures. The purchases occur while FCNCA trades at $1,803, down 17% year-to-date. Additional context in filings and analyst notes highlights the company’s valuation metrics, recent earnings, potential acquisition targets such as KeyCorp, and sector-wide concerns about private credit exposure.

Key Points

  • Frank B. Holding Jr. purchased 98 Class B shares at $1,550 each between March 17-19, 2026, for a total of $151,900; 92 shares were direct purchases on March 19 and six were indirect via a GRAT.
  • After the trades, Holding directly owns 2,841 Class B shares and holds significant additional Class A and Class B positions indirectly through trusts and custodianships.
  • First Citizens reported Q4 2025 core EPS of $51.27, beat expectations due to lower provisions, but saw pre-tax pre-provision income miss forecasts; the bank is pursuing acquisitions, including KeyCorp, to exceed $250 billion in assets.

Frank B. Holding Jr., who serves as chairman and chief executive officer of First Citizens BancShares (NASDAQ: FCNCA), disclosed purchases of 98 shares of the company's Class B common stock executed between March 17 and March 19, 2026. The shares were purchased at $1,550 each, for a total outlay of $151,900, according to a Form 4 filing with the Securities and Exchange Commission.

The filing breaks down the transactions: 92 shares were acquired directly on March 19, 2026, while six shares were recorded as indirect purchases through the Frank B. Holding Jr. 2025 #1 GRAT on March 17 and March 19. Following the reported trades, Holding directly holds 2,841 shares of Class B common stock. The filing also notes that he maintains substantial indirect ownership of both Class A and Class B shares through various trusts and custodial arrangements.

The insider purchases took place as First Citizens' shares traded at $1,803, a level that represents a 17% decline year-to-date. In valuation terms, InvestingPro's analysis cited in the disclosure indicates a price-to-earnings ratio of 10.92, suggesting the firm appears undervalued at current market levels. The company has raised its dividend for nine consecutive years and carries a market capitalization of $21.58 billion. Readers are directed to the Pro Research Report for additional data covering First Citizens and more than 1,400 other U.S. equities.

In operational and financial disclosures, First Citizens reported fourth-quarter 2025 core earnings per share of $51.27, beating analyst expectations, a result the company attributed largely to lower provisions. That said, the firm recorded pre-tax pre-provision income that fell short of forecasted levels.

On the analyst front, TD Cowen adjusted its price target for First Citizens BancShares to $2,500 from $2,600 while retaining a Buy rating. The firm’s strategic agenda, as disclosed publicly, includes pursuing acquisitions with the goal of surpassing the $250 billion asset threshold. Management has identified potential targets, including KeyCorp, as part of that effort. The bank says reaching that asset size is intended to strengthen its capacity to manage regulatory and compliance costs.

Additional sector context included a report from Raymond James highlighting heightened concerns around banks' private credit exposures. The report referenced recent auto bankruptcies that have intensified credit worries; those developments were attributed to alleged borrower fraud and have generated legal challenges. Raymond James noted that losses tied to these issues have been concentrated among a limited number of banks with specific credit exposures.

Separately, First Citizens Bank’s chairman and CEO, Frank Holding, was appointed to the Federal Reserve Board of Governors’ Federal Advisory Council for 2026, representing the Fifth District. The council role was noted alongside the other corporate developments disclosed in filings and analyst commentary.


The transactions reported on the Form 4, the company’s recent quarterly performance, analyst target revisions, strategic acquisition efforts, and broader concerns about private credit losses together paint a picture of a bank navigating valuation pressures, regulatory considerations, and targeted growth plans. The insider purchase is modest in size relative to the firm’s market capitalization and the broader strategic moves under consideration.

Risks

  • Private credit exposure in the banking sector - Raymond James highlights losses concentrated at a few banks tied to specific exposures, raising credit risk concerns for banks and investors.
  • Legal and credit uncertainties from recent auto bankruptcies - these events, attributed to alleged borrower fraud, have produced legal challenges that may affect banks with related exposures.
  • Regulatory and integration uncertainty tied to acquisition strategy - First Citizens’ aim to surpass $250 billion in assets to better manage regulatory and compliance costs introduces execution and regulatory risk for the banking and financial services sector.

More from Insider Trading

Revolution Medicines R&D Chief Sells $427,964 in Shares; Company Posts Q4 Loss Above Estimates Mar 19, 2026 Revolution Medicines CEO Sells $1.28 Million in Shares Under Pre‑Arranged Plan Mar 19, 2026 Revolution Medicines COO Disposes $455,918 in Stock as Shares Trade Near Yearly Peak Mar 19, 2026 Pale Fire Capital-led group buys $18.3M of Phreesia stock, raises stake to 7.65M shares Mar 19, 2026 Revolution Medicines General Counsel Disposes of Nearly $292,000 in RVMD Shares Mar 19, 2026